semaglutide and vision loss New study links Ozempic to ⚠️ NEW SAFETY ALERT ON

Led by Bridget Owens, PhD, RD, CNSC, we published our latest research in Eating Behaviors journal

This effect probably occurred due to the action of Vildagliptin, which inhibits the DPP-4 enzyme and increases GLP-1 half-life, triggering exocytosis of insulin granules 23 by activation of hexokinase after binding to its receptor

Speak with a licensed healthcare provider for personalized recommendations.

For those with absorption issues, gastrointestinal conditions, or severe deficiencies, injections provide a fast, reliable, and efficient solution that oral supplements simply cannot match

Mazdutide activates two receptors GLP-1 and glucagon